Clinical Trial Update: Treatment of PH With Angiotensin II Receptor Blocker and Neprilysin Inhibitor in HFpEF Patients With CardioMEMS Device [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating angiotensin receptor blocker and neprilysin inhibitor therapy for pulmonary hypertension in patients with a CardioMEMS device has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension

Snippet

Sponsor: Germans Trias i Pujol Hospital | Conditions: Pulmonary Hypertension | Phase 3 | Status: COMPLETED